U.S. election, rate uncertainty rattle Wall Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Oil slips on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Alaska LNG shipping savings justifies billions in investment, developer says
- Citi cuts investment banking analyst program to two years - Bloomberg
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- S&P 500 up, Nasdaq at record high as megacap tech stocks rise
- Paramount Skydance to close WBD deal, change ticker to SKYD
Valeant (VRX) 3Q Earnings Preview: Underlying RX Trends Remain Weak - Wells Fargo
November 1, 2016 7:54 AM EDTWells Fargo analyst David Maris issued a Q3 preview of Valeant Pharmaceuticals (NYSE: VRX), saying while the company should have some tailwinds for 3Q including price increases, cost cuts, and a now fixed Walgreens deal; however, Valeant's underlying U.S. prescription trends remain... More



